Jeffrey Dierks - 01 Jun 2021 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role
Chief Commercial Officer
Signature
/s/ Christian Ulrich, Attorney-in-fact for Jeffrey Dierks
Issuer symbol
HRMY
Transactions as of
01 Jun 2021
Net transactions value
$0
Form type
4
Filing time
15 Jun 2021, 17:13:26 UTC
Next filing
16 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRMY Stock Option Award $0 +53,900 $0.000000 53,900 01 Jun 2021 Common Stock 53,900 $33.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest with respect to half of the underlying shares on June 1, 2022 and with respect to the remaining shares, in forty-eight equal monthly installments beginning on July 1, 2022.

Remarks:

Chief Commercial Officer